Tag: OVER
Fewer Than Half of Drug Overdose Survivors Go to the Hospital
Findings show a potential missed opportunity for substance use treatment or harm reduction tools
ASA: Deaths From Fentanyl + Stimulants Rising in Older Adults
Gap sharply narrowed between older and younger adults from 2015 to 2023
Over-the-Counter Naloxone Shows Limited Uptake
Sales are a fraction of pharmacy-dispensed and program-distributed naloxone
59.0 Percent of Overdose Deaths Involved Stimulants in 2021 to 2024
People who died of overdoses involving stimulants and no opioids were older, more often had history of CVD
FDA Requiring Stronger Safety Labels for Opioid Medications
Updated opioid safety labeling is based on new data from two large postmarketing observational studies
Drug Overdoses in Health Care Workers Often Involve Drugs Obtained From Workplace
Opioids are most often the drug class implicated in causing death
Increase Seen in Reports of Lidocaine Poisonings and Mortality Since 2010
Following publication of advisories, reports of local anesthetic poisoning decreased, but reports of lidocaine poisoning and mortality increased
Disparities Exist in Outpatient Referrals for Opioid Use Disorder
Findings seen for Black patients presenting to the emergency department
U.S. Drug Overdose Deaths Started Declining in 2023
Monthly DOD rate declined by −0.36 per 100,000 from August 2023 to February 2024, accelerating through October 2024
Youth Deaths Attributable to Synthetic Opioids Alone Increasingly Predominant
Since 2020, fatal synthetic opioid-only overdose rates higher than polydrug overdose rates involving synthetic opioids
